ICON PLC (ICLR) Stock News

ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies

ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call

NASDAQ:ICLR is an undervalued gem with solid fundamentals.

When you look at ICON PLC (NASDAQ:ICLR), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.

Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?

Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN.

Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty

ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00–$15.00, citing biopharma spending cuts and biotech recovery delays.

ICON Issues Financial Guidance for Full Year 2025

Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey

ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research

ICON Announces Appointment of Chief Operating Officer

ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

The Law Offices of Frank R. Cruz Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

ICON Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

/PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether ICON Public Limited Company (NASDAQ: ICLR), any of its executive...

The Law Offices of Frank R. Cruz Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors

ICON plc to Present at the Jefferies London Healthcare Conference

ICON Reports Third Quarter 2024 Results

ICON plc Schedules Third Quarter 2024 Earnings Conference Call

ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape

ICON plc to Present at the Baird 2024 Global Healthcare Conference